DISEASE SCANNER
Global Incurable Diseases Tracker
Severe COPD
Advanced chronic obstructive pulmonary disease (GOLD grades 3-4, FEV1 <50% predicted). Characterized by persistent respiratory symptoms and airflow limitation. Third leading cause of death globally. Severe disease significantly impairs quality of life and increases mortality.
100.0M
111
Symptoms
Treatment Options
Risk Factors
Diagnostic Methods
- 1Spirometry (FEV1/FVC <0.70)
- 2Chest X-ray
- 3CT scan
- 4Arterial blood gas
- 5Alpha-1 antitrypsin testing
- 66-minute walk test
- 7Assessment of exacerbation frequency
Prognosis
Severe COPD significantly reduces life expectancy. BODE index predicts mortality. Frequent exacerbations accelerate decline. Respiratory failure common. 5-year survival approximately 40-70% depending on severity and comorbidities.
Prevention
- Smoking cessation (most important)
- Avoid occupational exposures
- Air pollution reduction
- Vaccinations
- Pulmonary rehabilitation
- Regular exercise
- Good nutrition
- Early treatment of exacerbations
Research Status
Triple therapy (LAMA/LABA/ICS) improves outcomes. Roflumilast for chronic bronchitis phenotype. Triple therapy reduces mortality. Lung volume reduction surgery and endobronchial valves for emphysema. MAC5 inhibitors in development. Stem cell therapy investigational.
Affected Countries
Sources
- https://www.cdc.gov/
- https://www.hematology.org/education/patients
- https://www.ncbi.nlm.nih.gov/books
- https://rarediseases.org/rare-diseases
Medical Disclaimer
This information is for educational purposes only. Always consult healthcare professionals for medical advice, diagnosis, and treatment.